Association between fatigue and sleep disturbances during treatment for pediatric acute lymphoblastic leukemia and posttreatment neurocognitive performance.
Priscilla VasquezJohanna EscalanteKimberly P RaghubarLisa S KahalleyOlga A TaylorIda Ki MooreMarilyn J HockenberryMichael E ScheurerAustin L BrownPublished in: Pediatric blood & cancer (2021)
Our findings indicate that fatigue and sleep disturbances during the first year of pediatric ALL therapy may impact long-term neurocognitive performance. Sleep and fatigue may be targets for intervention to preserve cognitive functioning in survivors.